DexCom (DXCM) Revenue — Quarter Ended Sep 30, 2023
Revenue in the reported quarter increased compared with both the immediately preceding quarter and the same quarter one year earlier. The year-over-year growth rate was higher than the sequential growth rate.
Key takeaway
Quarter ended Sep 30, 2023 · FY2023 Q3
Revenue in the reported quarter increased compared with both the immediately preceding quarter and the same quarter one year earlier. The year-over-year growth rate was higher than the sequential growth rate.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$975M
Revenue reported for this quarter.
Quarter-over-quarter
+11.9%
Change from the immediately preceding quarter.
Year-over-year
+26.7%
Change from the comparable year-ago quarter.
Trailing four quarters
$3.4B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Dec 31, 2022 | $815.2M | +16.8% |
| Mar 31, 2023 | $741.5M | +17.9% |
| Jun 30, 2023 | $871.3M | +25.2% |
| Sep 30, 2023 | $975M | +26.7% |
Revenue performance
Revenue rose from the immediately preceding quarter, continuing an upward trajectory. The increase was consistent with the company's recent operating results.
Quarterly comparison
The year-over-year revenue increase was larger than the sequential increase from the immediately preceding quarter. The rate of sequential growth moderated compared with the prior quarter's sequential growth.
What to watch
The sequential revenue growth slowed relative to the previous quarter's pace, which may warrant monitoring in future periods.